Related Experiment Video
Updated: Aug 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation
Evguenia Strom1, Swati Sathe, Pavel G Komarov
1Cleveland BioLabs, Inc., 11000 Cedar Ave., Cleveland, Ohio 44106, USA.
Abstract:
p53-dependent apoptosis contributes to the side effects of cancer treatment, and genetic or pharmacological inhibition of p53 function can increase normal tissue resistance to genotoxic stress. It has recently been shown that p53 can induce apoptosis through a mechanism that does not depend on transactivation but instead involves translocation of p53 to mitochondria. To determine the impact of this p53 activity on normal tissue radiosensitivity, we isolated a small molecule named pifithrin-mu (PFTmu, 1) that inhibits p53 binding to mitochondria by reducing its affinity to antiapoptotic proteins Bcl-xL and Bcl-2 but has no effect on p53-dependent transactivation. PFTmu has a high specificity for p53 and does not protect cells from apoptosis induced by overexpression of proapoptotic protein Bax or by treatment with dexamethasone (2). PFTmu rescues primary mouse thymocytes from p53-mediated apoptosis caused by radiation and protects mice from doses of radiation that cause lethal hematopoietic syndrome. These results indicate that selective inhibition of the mitochondrial branch of the p53 pathway is sufficient for radioprotection in vivo.
Insights
Pifithrin-mu selectively inhibits the mitochondrial pathway of p53-dependent apoptosis. This molecule protects normal tissues from radiation damage, offering potential for improved cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Radiotherapy
Background:
- p53-dependent apoptosis is a key factor in cancer treatment side effects.
- p53 can induce apoptosis via mitochondrial translocation, independent of transactivation.
- Targeting this mitochondrial pathway may enhance normal tissue resistance to genotoxic stress.
Purpose of the Study:
- To investigate the impact of inhibiting the mitochondrial p53 pathway on normal tissue radiosensitivity.
- To identify and characterize a small molecule inhibitor of p53 mitochondrial translocation.
Main Methods:
- Isolation and characterization of pifithrin-mu (PFTmu), a novel small molecule.
- Assessing PFTmu's effect on p53 binding to mitochondria and interaction with Bcl-xL and Bcl-2.
- Evaluating PFTmu's specificity and protective effects in primary mouse thymocytes and mice exposed to radiation.
Main Results:
- Pifithrin-mu (PFTmu) selectively inhibits p53's mitochondrial translocation without affecting transactivation.
- PFTmu demonstrates specificity for p53 and does not protect against apoptosis induced by Bax or dexamethasone.
- PFTmu rescues mouse thymocytes from radiation-induced apoptosis and protects mice from lethal radiation doses.
Conclusions:
- Selective inhibition of the mitochondrial p53 pathway is sufficient for in vivo radioprotection.
- PFTmu represents a promising therapeutic agent for mitigating radiation-induced normal tissue damage in cancer patients.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

